首站-论文投稿智能助手
典型文献
Retinol-binding protein-4 and nonalcoholic fatty liver disease
文献摘要:
Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common as the global economy grows and living standards improve. Timely and effective preventions and treatments for NAFLD are urgently needed. Retinol-binding protein-4 (RBP4), the protein that transports retinol through the circulation, was found to be positively related to diabetes, obesity, cardiovascular disease, and other metabolic diseases. Observational studies on the association between serum RBP4 level and the prevalence of NAFLD found contradictory results. Some of the underlying mechanisms responsible for this association have been revealed, and the possible clinical implications of treating NAFLD by targeting RBP4 have been demonstrated. Future studies should focus on the predictive value of RBP4 on NAFLD development and its potential as a therapeutic target in NAFLD.
文献关键词:
Nonalcoholic fatty liver disease;Retinol-binding protein-4;Metabolic disease
作者姓名:
Huang Hangkai;Xu Chengfu
作者机构:
Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China
引用格式:
[1]Huang Hangkai;Xu Chengfu-.Retinol-binding protein-4 and nonalcoholic fatty liver disease)[J].中华医学杂志(英文版),2022(10):1182-1189
A类:
preventions
B类:
Retinol,binding,protein,nonalcoholic,fatty,liver,Nonalcoholic,NAFLD,becoming,increasingly,common,global,economy,grows,living,standards,improve,Timely,effective,treatments,are,urgently,needed,RBP4,that,transports,retinol,through,circulation,was,found,positively,related,diabetes,obesity,cardiovascular,other,metabolic,diseases,Observational,studies,association,between,serum,level,prevalence,contradictory,results,Some,underlying,mechanisms,responsible,this,have,been,revealed,possible,clinical,implications,treating,by,targeting,demonstrated,Future,should,focus,predictive,value,development,its,potential,therapeutic,Metabolic
AB值:
0.613415
相似文献
Lingguizhugan Decoction,a Chinese herbal formula,improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease:a translational approach
Liang Dai;Jingjuan Xu;Baocheng Liu;Yanqi Dang;Ruirui Wang;Lijie Zhuang;Dong Li;Lulu Jiao;Jianying Wang;Lei Zhang;Linda L.D.Zhong;Wenjun Zhou;Guang Ji-Institute of Digestive Diseases,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Clinical Research Academy,Peking University Shenzhen Hospital,Shenzhen 518032,China;Department of Integrated Traditional and Western Medicine,Jinling Hospital,Medical School of Nanjing University,Nanjing 210002,China;Shanghai Innovation Centre of TCM Health Service,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Sanlin Health Centre of Pudong New District,Shanghai 200120,China;Zhangjiang Health Centre of Pudong New District,Shanghai 201203,China;Beicai Health Centre of Pudong New District,Shanghai 201204,China;Hong Kong Chinese Medicine Study Centre,Hong Kong Baptist University,Hong Kong 999077,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
Hao Shen;Han Yu;Qian-yu Li;Ya-ting Wei;Jing Fu;Hui Dong;Dan Cao;Lin-na Guo;Lei Chen;Yuan Yang;Ying Xu;Meng-chao Wu;Hong-yang Wang;Yao Chen-International Cooperation Laboratory on Signal Transduction,National Center for Liver Cancer,Ministry of Education Key Laboratory on signaling Regulation and Targeting Therapy of Liver Cancer,Shanghai Key Laboratory of Hepato-biliary Tumor Biology,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University/NAVAL Medical University,Shanghai 200433,China;Department of Pathology,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Metabolism and Integrative Biology,Fudan University,Shanghai 200438,China;Third Department of Hepatic Surgery,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200433,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。